Why the study?
Does PDMA improve gene delivery efficiency and reduce toxicity compared to PEI in neonatal mouse cardiomyocytes?
Does PDMA improve gene delivery efficiency and reduce toxicity compared to PEI in neonatal mouse cardiomyocytes?
PDMA is an effective and low-toxicity gene delivery carrier for neonatal mouse cardiomyocytes, offering a safer alternative to PEI.
No takes yet. Share an insight, caveat, or question.
Supports PDMA as a candidate vector for cardiomyocyte transfection; hypothesis-generating and should not yet change practice.
Xu et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: